Heart :: MUSC helps turn heart guidelines into lifelines
The Medical University of South Carolina, (MUSC) was recognized for participating in an American Heart Association and American Stroke Association program called Get With the Guidelines.
Management
Biotechnology :: Acorda Therapeutics Responds to Third Point Letter
Acorda Therapeutics, Inc. (NASDAQ:ACOR) announced that it has received a letter from Third Point LLC dated February 22, 2007.
Healthcare :: Matria Healthcare’s 2006 results and guidance for 2007
Matria Healthcare, Inc. (NASDAQ:MATR) announced its financial results for the fourth quarter and year ended December_31, 2006.
Hepatitis :: Positive opinion for hepatitis B drug Sebivo
On 22 February 2007 the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending to grant a marketing authorisation for the medicinal product Sebivo, 600 mg, film-coated tablet intended for treatment of chronic hepatitis B virus (HBV) infection in adult patients.
NHS :: Regulation of NHS doctors and other health care professionals
The King?s Fund broadly welcomed the government?s White Paper on the regulation of doctors and other health care professionals, hailing the proposals as a good deal for patients, the public and the medical profession.
Health Insurance :: Private health insurance premiums increase
In Australia, figures released by the Private Health Insurance Administration Council (PHIAC) show that as a result of benefits paid to patients and rising health service costs, private health premiums will increase by an average of 4.5 per cent from 1 April this year.
Prostate Cancer :: Men with prostate cancer more optimistic after several years of treatment than at diagnosis
Men being treated for prostate cancer feel more optimistic about their condition over time, reflecting their positive experience of treatment and the high level of trust they have in their specialist physician, according to results from a global survey1 providing unique insight into men’s experience of this common cancer.
Insulin :: Lilly’s unique insulin pen HumaPen MEMOIR
Eli Lilly and Company announced the launch of the first insulin pen with memory, HumaPen(R) MEMOIR(TM), to help simplify the daily management of diabetes.
ADHD :: ADHD Patient Medication Guides to alert patients about risks
US FDA directs ADHD drug manufacturers to notify patients about cardiovascular adverse events and psychiatric adverse events.
HIV :: Pay more attention to genital herpes infections in HIV-infected persons
The association between genital herpes and higher viral loads of HIV-1 in HIV-infected persons is strong enough to warrant more routine testing for the herpes virus in HIV-positive patients, as well as additional clinical studies of the co-infections, according to an editorial to be published in the Feb. 22 New England Journal of Medicine.